Survey reveals cancer is most 'feared' disease

By Admin
Share
A new study has revealed that cancer is the most feared disease among adults, ahead of Alzheimers and HIV. Thirty-five percent of adults are most scare...

A new study has revealed that cancer is the most feared disease among adults, ahead of Alzheimer’s and HIV.

Thirty-five percent of adults are most scared about developing cancer than any other illness, a Cancer Research UK survey of 2,000 adults found.

The most feared type of cancer is brain cancer, as people think it has the worst symptoms and is the cancer that people are most likely to die from.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

After brain cancer, women are most worried about developing breast cancer despite 21 percent of people thinking it had the best survival rates.

Meanwhile, the second most feared cancer among men was bowel cancer, closely followed by lung cancer and prostate cancer.

The survey found only two percent of people were worried about getting skin cancer, despite cases of skin cancer rising and the increased popularity of sunbeds.

The Director of Cancer Information at Cancer Research UK, Dr Lesley Walker, said: “Cancer is a very emotive subject and it's understandable why so many people fear it among other diseases, but people should be reassured that we are doing all we can to find new treatments for the disease.”

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma